Possible Induction of Graves' Disease and Painless Thyroiditis by Gonadotropin-Releasing Hormone Analogues
Authors:
- 1 August 2003
- journal article
- case report
- Published by SAGE Publications in Thyroid®
- Vol. 13 (8) , 815-818
Abstract
Prolonged administration of gonadotropin-releasing hormone (GnRH) analogues induce a decrease in serum estrogen level, which may aggravate subclinical or mild autoimmune thyroid disease. Two patients developed Graves' thyrotoxicosis in association with an increase in anti-thyrotropin (TSH) receptor antibody activities at 4 months after initiation of buserelin acetate. GnRH analogue therapy was discontinued at the time of diagnosis but it took more than 2 years of methimazole therapy to obtain remission of Graves' disease. Another patient developed painless thyroiditis in association with an increase in antithyroid microsomal antibodies at 4 months after initiation of leuprolide acetate. These results indicate that GnRH analogues possibly induce clinical onset of Graves' thyrotoxicosis or destruction-induced thyrotoxicosis. Clinicians should be aware of this phenomenon. All patients who are to receive GnRH analogue therapy should be examined for antithyroid antibodies and family history of autoimmune thyroid disease, and should be followed accordingly.Keywords
This publication has 18 references indexed in Scilit:
- Practical Treatment with Minimum Maintenance Dose of Anti-Thyroid Drugs for Prediction of Remission in Graves' Disease.Endocrine Journal, 2003
- Simple and practical parameters for differentiation between destruction‐induced thyrotoxicosis and Graves’ thyrotoxicosisClinical Endocrinology, 2002
- Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunctionGynecological Endocrinology, 2000
- Postpartum Autoimmune Thyroid Syndrome.Endocrine Journal, 2000
- Postpartum Autoimmune Thyroid Syndrome: A Model of Aggravation of Autoimmune DiseaseThyroid®, 1999
- Increased Risk of Autoimmune Thyroid Disease in Hepatitis C vs Hepatitis B Before, During, and After Discontinuing Interferon TherapyArchives of internal medicine (1960), 1998
- Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective studyThe Journal of Clinical Endocrinology & Metabolism, 1996
- Onset of Graves' Thyrotoxicosis after an Attack of Allergic RhinitisThyroid®, 1996
- LeuprorelinDrugs, 1994
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984